CanaQuest Medical Corp is a Canadian biotechnology company. It mainly focuses on the development of proprietary research and products utilizing cannabis, hemp, and algae oils.

CANAQUEST MED CORP by CanaQuest Medical Corporation

CanaQuest Medical

<ul>
<li>One of&nbsp;Tesla Inc&rsquo;s&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) top four executives and ex-president Jerome Guillen, who left the company in the first week of June, has sold an estimated $274 million worth of Tesla shares after exercising stock options,&nbsp;<a class="editor-rtfLink" href="https://www.reuters.com/business/autos-transportation/ex-tesla-president-sold-stocks-worth-247-million-since-june-10-sec-filing-2021-06-18/" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Reuters reported</a>.</li>
<li>According to the Securities and Exchange Commission (SEC) filing, Guillen expected to sell 215,718 shares for $129 million on Tuesday. He offloaded another 145,289 stocks worth $89.6 million on June 14 and 90,111 shares worth $55 million on June 10.</li>
<li>Guillen, a former Mercedes engineer, worked at Tesla directly under CEO Elon Musk since November 2010.</li>
<li>After serving in the automotive business, he moved to the nascent heavy trucking line in March 2021. Just after spending three months in the department, he left the company on June 3.&nbsp;&nbsp;</li>
<li>According to the report, Guillen&rsquo;s departure has sparked speculations about Tesla&rsquo;s future vehicle programs.</li>
<li>As president of Automotive, Tesla opened its first plant overseas in Shanghai and expanded its battery cell supply partnerships.</li>
<li>Guillen is the second high-level exec to leave in recent months. In April, former vice president of legal Al Prescott left the company.</li>
<li>Price Action:&nbsp;TSLA shares closed 1.09% higher at $623.33 on Friday.</li>
</ul>

News

Media

General

TSLA

Tesla's Ex-President Jerome Guillen Offloaded Stock Worth $274M Since June 10

Keeping a tough stance on cryptocurrencies, China has issued an order to crack down on crypto mining operations in Sichuan&rsquo;s southwest province,&nbsp;<a class="editor-rtfLink" href="https://www.reuters.com/technology/chinas-cryptocurrency-mining-crackdown-spreads-sichuan-2021-06-19/" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Reuters</a>&nbsp;reported.&nbsp;
What Happened:&nbsp;On Friday, the Sichuan branch of the National Development and Reform Commission (NDRC) and the Sichuan Energy Bureau ordered cryptocurrency mining projects closed in the major mining center.
The Commission demanded the closure of 26 suspected cryptocurrency mining projects by Sunday in the province.&nbsp;
The authorities have ordered state electricity companies in Sichuan to conduct inspections and make corrections. In addition, they have been asked to immediately stop supplying electricity to crypto-mining projects, which they have detected.
They urged the local governments in Sichuan to start combing for crypto-mining projects and shut them down.&nbsp;
In Sichuan, miners use hydropower to run computer equipment to verify&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Bitcoin</a>&nbsp;(CRYPTO: BTC) transactions.
According to the data carried by the University of Cambridge, Sichuan is China&rsquo;s second-biggest bitcoin mining province. At this place, miners move their activities in the rainy summer to take advantage of its rich hydropower resources.
Mitchell&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/markets/cryptocurrency/21/06/21600974/exclusive-building-on-top-of-bitcoin-may-not-be-as-popular-as-ethereum-other-blockchains-b" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Cuevas</a>, Head of Growth at the Stacks Foundation, says that &lsquo;Proof of Work&rsquo; is the mining mechanism used by Bitcoin that requires solving complex mathematical puzzles, requiring power-hungry computing resources.
Why It Matters:&nbsp;Sichuan&rsquo;s crackdown indicates that China&rsquo;s displeasure with cryptocurrency mining extends beyond cases.&nbsp;
Other mining centers, including Xinjiang, Inner Mongolia, and Yunnan, have ordered crackdowns on bitcoin mining.
In May, Chinese Vice Premier Liu He called for a &ldquo;severe&rdquo; crackdown, reiterating the government&rsquo;s position on cryptocurrencies.
China&rsquo;s Inner Mongolia region has proposed punishments for companies and individuals involved in crypto mining.
According to&nbsp;<a class="editor-rtfLink" href="https://www.reuters.com/article/us-crypto-currency-sichuan-mining/in-widening-chinese-bitcoin-crackdown-sichuan-to-probe-cryptomining-official-idUSKCN2D81B0" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Reuters</a>, Chinese energy regulators are meeting local power companies to collect information on mining farms.&nbsp;
China is the world&rsquo;s most prominent cryptocurrency mining location, accounting for 75% of the Bitcoin hash rate.&nbsp;
In 2017, It shut down all local crypto exchanges and initial coin offerings (ICOs).
Price Action:&nbsp;At press time, BTC traded 0.22% higher at $35,900 on Saturday.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

China's Cryptocurrency Mining Crackdown Intensifies, Spreads To Sichuan

<ul>
<li>The E.U. antitrust regulators are set to open an investigation into&nbsp;Alphabet Inc&#39;s&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) subsidiary Google&#39;s digital advertising practices,&nbsp;<a class="editor-rtfLink" href="https://www.reuters.com/technology/eu-antitrust-regulators-probe-googles-adtech-business-by-year-end-sources-2021-06-18/" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Reuters</a>&nbsp;reported.&nbsp;&nbsp;</li>
<li>The regulators are expected to open the investigation by the end of 2021.&nbsp;</li>
<li>The E.U. competition watchdog has fined the company more than $9.8 billion for blocking rivals in online shopping in the last decade.</li>
<li>Last week, France settled with Google for $268 million and various commitments over allegations related to the network business.</li>
<li>European Union Competition Commissioner Margrethe Vestager has said that Google faces an &quot;extensive investigation&quot; into its advertising business, adding a new front to a decade-long antitrust battle,&nbsp;<a class="editor-rtfLink" href="https://www.bloomberg.com/news/articles/2021-03-12/google-faces-very-large-eu-advertising-probe-vestager-says?sref=TBDibEcD" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Bloomberg</a>&nbsp;reported.&nbsp;</li>
<li>The E.U. has been examining Google&#39;s data practices since 2019 and has widened the scope to look at Google&#39;s plans to phase out third-party cookies, the report says.&nbsp;</li>
<li>The investigation would focus on Google&#39;s position vis-a-vis advertisers, publishers, intermediaries, and rivals.&nbsp;</li>
<li>In 2020, the U.S. Justice Department also sued Google for abusing its dominance in search ads.</li>
<li>A group of states led by Texas has filed a lawsuit focused on anti-competitive behavior on the network side of the company.</li>
<li>According to the market researcher&nbsp;<a class="editor-rtfLink" href="https://www.emarketer.com/content/google-collects-more-than-half-of-all-us-search-ad-revenue" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">eMarketer</a>, Google will control 27% of global online ad spending in 2021, including 57% for search ads and 10% for display.</li>
<li>Google has made $147 billion in revenue from online ads in 2020, more than any other company in the world. About 16% of the revenue came from its display or network business.</li>
<li>Advertisers and rivals have claimed that dependence on Google gives the company an unfair advantage, which allows the company to extract high fees from all sides and block rivals.</li>
<li>Price Action:&nbsp;GOOG shares closed 0.64% lower at $2,511.35 on Friday.</li>
</ul>

Government

Regulations

Legal

Tech

GOOG

GOOGL

Google's Adtech Business To Undergo Stringent EU Antitrust Probe

Volkswagen Group&rsquo;s&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/vwagy#OTC">VWAGY</a>)&nbsp;Audi will not introduce cars based on petrol and diesel engines from 2026.&nbsp;
What Happened:&nbsp;According to the German publication,&nbsp;<a class="editor-rtfLink" href="https://www.sueddeutsche.de/wirtschaft/audi-verbrenner-elektromobilitaet-1.5325505?reduced=true" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">S&uuml;ddeutsche Zeitung</a>, Audi will stop introducing new ICE vehicles from 2026.&nbsp;
Audi has introduced electric vehicles in the last few months, including the e-Tron GT, Q4 e-Tron, and Q4 Sportback e-Tron.&nbsp;
Duesmann&rsquo;s report mentions there will be no hybrid vehicles either. Instead, it looks like the company will be going EV-only soon.
Audi will launch its final ICE-powered vehicle, the Q5, in 2026, which will be manufactured through to 2033, the report says.&nbsp;
The company has said that it would not continue to develop its range of internal combustion engines. As a result, the A3 and A4 models will not have ICE-powered successors, Reuters reports.&nbsp;
Audi is planning to phase out internal combustion engines by 2035.&nbsp;
Why It Matters:&nbsp;Audi&rsquo;s move to phase out ICE vehicles depends on the EV&rsquo;s success and the plant&rsquo;s switchover plans. Audi is planning to launch EVs A6 E-Tron and the Q5 E-Tron by 2022.&nbsp;
Vehicle manufacturers have announced they will stop producing or selling fossil fuel-burning vehicles. In addition, countries across the globe are banning internal combustion vehicles.&nbsp;
The announcement makes Audi the first major brand from Germany to go the fully electric path soon.&nbsp;Mercedes-Benz&nbsp;aims to kill ICE production by 2039, while&nbsp;Bayerische Motoren Werke&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/bmwyy#OTC">BMWYY</a>) has not confirmed a date yet.
Toyota Motor Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tm#NYSE">TM</a>)&nbsp;recently&nbsp;outlined plans to transition from internal combustion vehicles toward eco-friendly electric cars.&nbsp;
Image Courtesy: Audiusa

BMWYY

VLKAF

VWAGY

Audi Will Not Introduce ICE Vehicles After 2026, No Hybrid Vehicles Either

Cathie Wood-led Ark Investment Management on Friday snapped up 87,900 shares, worth about $6.29 million, in JD.com Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) on the dip.
Shares of the company, a key rival to Alibaba Group Holding (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baba#NYSE">BABA</a>) in the e-commerce space in China, closed 2.56% lower at $71.62 on Friday.
The New York-based investment firm has been piling up shares in Alibaba rivals, some of which now account for a better part of its holdings compared to the Jack Ma-led company.
Wood&rsquo;s firm deployed Ark Fintech Innovation ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/arkf#NYSE">ARKF</a>) to buy JD.com shares on Friday, lifting ARKF&rsquo;s holding to 1.8 million, worth about $132.82 million. JD.com ranks seventh among a portfolio of 43 stocks in ARF.
On a consolidated basis, Ark holds 5.89 million shares, worth about $433.6 million, via the four ETFs.&nbsp;
Ark Invest also holds shares of JD.com via Ark Space Exploration &amp; Innovation ETF (BATS: <a class="ticker" href="https://www.benzinga.com/stock/arkx#BATS">ARKX</a>), Ark Autonomous Technology &amp; Robotics ETF (BATS: <a class="ticker" href="https://www.benzinga.com/stock/arkq#BATS">ARKQ</a>) and Ark Next Generation Internet ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/arkw#NYSE">ARKW</a>).&nbsp;
The Beijing-headquartered JD.com runs one of the two massive B2C online retailers in China and is a major competitor to Alibaba-run Tmall. The investment firm also holds shares in JD.com&rsquo;s supply chain arm JD Logistics listed on the Hong Kong exchange.&nbsp;
Ark Invest has been <a href="https://www.benzinga.com/markets/penny-stocks/21/05/21121077/cathie-wood-sheds-33-6m-alibaba-shares-on-earnings-day" style="text-decoration:none">shedding</a> shares of Alibaba but still holds 424,428 shares, worth $89.8 million, via ARKX, ARKQ and ARKF.&nbsp;
See Also: <a href="https://www.benzinga.com/etfs/sector-etfs/21/05/21027556/cathie-wood-loads-up-another-28m-worth-of-shares-in-alibaba-rival-jd-com" style="text-decoration:none">Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com</a>
The popular investment firm also sold 34,135 shares, estimated to be worth about $17.1 million, in video streaming company Netflix Inc(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>).
Netflix shares closed 0.49% higher at $500.77 on Friday.
The investment firm sold the shares of the company via the ARK Next Generation Internet ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/arkw#NYSE">ARKW</a>). It also holds shares of the online streaming service via the Ark Space Exploration &amp; Innovation ETF (BATS: <a class="ticker" href="https://www.benzinga.com/stock/arkx#BATS">ARKX</a>).
Together, ARKW and ARKX still hold 139,297 shares, worth about $69.4 million in Netflix.
See Also: <a href="https://www.benzinga.com/markets/penny-stocks/21/05/21144625/cathie-wood-buys-26m-disney-shares-and-sells-13m-in-netflix-what-you-need-to-know" style="text-decoration:none">Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know</a>
Ark&rsquo;s other key sells on Friday included Galileo Acquisition Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gleo#NYSE">GLEO</a>) and buys included Blade Air Mobility Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blde#NASDAQ">BLDE</a>).
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/NUehKZBLBCQ" width="560"></iframe>

Sector ETFs

Trading Ideas

ETFs

ARKF

ARKQ

ARKW

ARKX

BABA

BLDE

GLEO

NFLX

Cathie Wood Buys Another $6.3M In Alibaba Rival JD And Sells $17M In Netflix

Dogecoin (CRYPTO: DOGE) and other meme coins have been in the <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21543180/shiba-inu-outperforms-dogecoin-as-meme-coins-see-rekindled-social-media-interest" style="text-decoration-line:none">spotlight this year</a> as they soared to sky-high levels, but there is a cryptocurrency that wants to take the meme hoopla and raise it to the nth level. Meet Tetherino, a project that takes a dig at stablecoins and in particular Tether (CRYPTO: USDT), which it calls its &ldquo;step-brother.&rdquo;
See Also: <a href="https://www.benzinga.com/money/best-stablecoins-and-4-types-of-stablecoins/" style="text-decoration-line:none">Best Stablecoins</a>&nbsp;
Commercial Toilet Paper: &ldquo;We hoped the Dogecoin mania would be the end of crypto, by exposing how ridiculous crypto valuations are. But we were wrong,&rdquo;&nbsp;Tetherino Chief Technology Officer, who goes by the pseuodnym&nbsp;Paolino Ardoino, told Benzinga&nbsp;on motivation behind the&nbsp;&ldquo;commercial toilet paper&rdquo; inspired project and its coin TTR.&nbsp;&nbsp;
<img alt="Screen-Shot-2021-06-19-at-7-29-11-PM" src="https://i.ibb.co/80TygVm/Screen-Shot-2021-06-19-at-7-29-11-PM.png" style="height:343px; width:650px" />
Image: How Tetherino Describes Itself On Its Website, With &quot;Pumping The Markets&quot; As A Stated Goal
&ldquo;So we decided to create the most ridiculous cryptocurrency that could exist, and make it successful in terms of liquidity, adoption, and market cap, to do the job that Dogecoin failed to accomplish.&rdquo;
So while Tetherino is not inspired by Dogecoin, it certainly wants to outshine it as a joke cryptocurrency. Ardoino revealed that the project was inspired by Tether itself and pointed to the stablecoin&rsquo;s &ldquo;commercial paper&rdquo; backing that led to Tetherino opting for &ldquo;commercial toilet paper.&rdquo;
Ardoino&nbsp;argued that Tetherino&rsquo;s backing is &ldquo;more real and valuable&rdquo; than Tether&rsquo;s.&nbsp;
&ldquo;The impossibility to redeem stablecoins led us to introduce an actual &quot;redemption&quot; feature for Tetherinos, where you can receive actual (commercial) toilet paper rolls by sending back tetherinos to our Treasury account.&rdquo;
See Also:&nbsp; <a href="https://www.benzinga.com/markets/cryptocurrency/21/03/20313045/7-strange-things-you-can-own-as-a-non-fungible-token-nft" style="text-decoration-line:none">7 Strange Things You Can Own As A Non-Fungible Token (NFT)</a>
Another inspiration for Tetherino was XRP (CRYPTO: XRP) and their liquidity provider claims, as per Ardoino. <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="text-decoration-line:none">Bitcoin</a> (CRYPTO: BTC) &ldquo;comedy gold&rdquo; is an inspiration for Tetherino&rsquo;s memes and image.&nbsp;
<img alt="Screen-Shot-2021-06-19-at-7-29-47-PM" src="https://i.ibb.co/3dr7Jr3/Screen-Shot-2021-06-19-at-7-29-47-PM.png" style="height:230px; width:650px" />
Image: A quote from Warrenino Buffetino, an &quot;early backer&quot; of Tetherino.
Why Aim At Tether? On why Tetherino is training its guns at Tether and other stablecoins with its parody, Ardoino told Benzinga that&nbsp;&ldquo;the roots of Tether run very deep in the whole cryptocurrency ecosystem.&quot;
&quot;Its parent company, iFinex, also owns the exchange Bitfinex, and has a stake in Blockstream, where most of Bitcoin Core dev team originates from.&rdquo;
&ldquo;The bull market that started in March 2020 co&iuml;ncided with Binance&rsquo;s decision to accept Tether as collateral for leveraged trading. The [circumstantial] evidence that Tether, and the team behind it, are at the core of the crypto ecosystem and market, is overwhelming,&rdquo; explained Ardoino.
The Tetherino CTO decried Tether&rsquo;s alleged lack of credibility. He said, &ldquo;They are a joke to whoever has any real experience in finance and banking.&rdquo;&nbsp;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21582799/tether-usdt-and-binance-coin-bnb-are-likely-targets-for-sec-lawsuit-says-crypto-legal-expe" style="text-decoration-line:none">Tether (USDT) And Binance Coin (BNB) Are Likely Targets For SEC Lawsuit, Says Crypto Legal Expert</a>
&ldquo;They have no proper reporting standards, don&rsquo;t comply to any accounting standards, have no oversight, no funds segregation procedures. They just make stuff up as they go. Yet nobody dares question them, probably because they are so deeply rooted in the crypto ecosystem. We believe that Tether going bust would be a disaster to the crypto markets,&rdquo; decried Ardoino.
<img alt="Screen-Shot-2021-06-19-at-7-29-27-PM" src="https://i.ibb.co/FwSNKpp/Screen-Shot-2021-06-19-at-7-29-27-PM.png" style="height:230px; width:650px" />
Image: Quote from Elonoino Mosquito, also an &quot;early backer&quot; of Tetherino.
On Pump And Dump: Ardoino blames an institutional &ldquo;blank confidence check&rdquo; as the ailment plaguing the cryptocurrency ecosystem. On Tether, he claimed, &ldquo;They can buy print USDT to buy and pump up Bitcoin, and then unload Bitcoin on cash exchanges.&rdquo;
Ardoino conceded that pumps and dumps exist in all markets when asked about the manipulative scheme in the wider context. However, he pointed that the difference is in oversight, transparency, and incentives such as the rule of law.&nbsp;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/20/03/15514013/arizona-republican-introduces-draft-bill-to-clarify-regulators-for-crypto-assets" style="text-decoration-line:none">Arizona Republican Introduces Draft Bill To Clarify Regulators For Crypto Assets</a>
&ldquo;The Federal Reserve, for instance, has &#39;financial stability&#39; as one of its mandates,&rdquo; said Ardoino &mdash;&nbsp;adding, &ldquo;Mr Powell, the chairman of the Fed, for instance, couldn&rsquo;t manipulate the S&amp;P500 by printing himself a trillion dollars and buying stocks to pump them up and dump them on retail investors, cashing in the profits. Tether absolutely could. That&rsquo;s the big problem.&rdquo;
Community, Not Coins: Tetherino&rsquo;s mission is to spread awareness concerning problems inherent to the cryptocurrency ecosystem, revealed Ardoino. In that respect, the community surrounding the project is more valuable than the token.
&ldquo;We need the community for creativity, insights, and of course, memes,&rdquo; said Ardoino.&nbsp;
&ldquo;If one day the Tetherino token reaches a billion USD in market cap, that&rsquo;s a fact you just couldn&rsquo;t ignore and brush away - people would have to talk about it, which would in turn attract the wider audience&rsquo;s attention to our message,&rdquo; explained Ardoino.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/06/21560882/dogecoin-a-victim-of-pump-and-dump-scheme-by-elon-musk-says-analyst" style="text-decoration-line:none">Dogecoin A &#39;Victim Of Pump And Dump Scheme&#39; By Elon Musk, Says Analyst</a>
Cover photo by&nbsp;Here and now, unfortunately, ends my journey on Pixabay&nbsp;from&nbsp;<a href="https://pixabay.com/photos/toilet-paper-sold-out-4942737/">Pixabay</a>

Exclusives

$DOGE

$TTR

$USDT

$XRP

EXCLUSIVE: Dogecoin Mania Didn't Prove 'The End Of Crypto,' So They Launched Commercial Toilet Paper-Backer Tetherino, 'The Most Ridiculous Cryptocurrency' Ever

Caesars Sportsbook&nbsp;has released its win totals for the upcoming college football season. Alabama and Clemson have the highest projected win totals, both at 11.5.
What To Know: Clemson and Alabama have been College Football Playoff staples since its enactment in 2014. Led by coaches Dabo Swinney and Nick Saban, both of these schools dominate their respective conferences, the ACC and SEC.
Both teams lost their starting quarterbacks to the NFL draft, Trevor Lawrence and Mac Jones, but have two five-star quarterbacks ready to take the helm in&nbsp;D.J. Uiagalelei and Bryce Young.
Following them with 11 wins are Ohio State and Oklahoma. Ohio State lost the 2021 College Football National Championship to Alabama, but managed to retain a lot of talent such as wide receiver Chris Olave. Oklahoma is led by offensive guru Lincoln Riley and preseason Heisman contender Spencer Rattler.
See Also: <a href="https://www.benzinga.com/news/21/06/21477502/alabamas-nick-saban-signs-contract-extension-here-are-crimson-tide-betting-odds-for-2021">Alabama&#39;s Nick Saban Signs Contract Extension: Here Are Crimson Tide Betting Odds For 2021</a>
Who&#39;s Next? Georgia&rsquo;s is set at 10.5 while North Carolina has 10.
Georgia has had some nice seasons under Kirby Smart, but has fallen short of the National Championship every season, including their 2018 overtime loss to Alabama. North Carolina has Heisman contender Sam Howell taking snaps under center, but lost both of their 1,000-yard rushers from last season, Javonte Williams and Michael Carter, to the draft.
Also with 10 are two non-Power 5 teams: Coastal Carolina and Cincinnati.
Coastal Carolina came out of nowhere last season, going 11-0 in the regular season before an overtime loss to Liberty in the FBC Mortgage Cure Bowl. Cincinnati also had a phenomenal season last year, going 9-0 in the regular season, but lost their bowl game to Georgia.
The lowest win totals went to Bowling Green, Kansas, Louisiana-Monroe, UMASS and UNLV, all with 1.5.

Sports

Caesars Sportsbook Announces College Football Win Totals For 2021: 2 Non-Power 5 Teams Projected Over 10?

Since 1989, &ldquo;The Simpsons&rdquo; has entertained fans around the world and provided references to pop culture and current world events.
An episode in 2013 featured the first mention of <a href="https://www.benzinga.com/money/how-to-buy-bitcoin/">Bitcoin </a>(CRYPTO:BTC) on the show.
Simpsons Episode: An episode called &ldquo;Yellow Subterfuge&rdquo; <a href="https://simpsons.fandom.com/wiki/Yellow_Subterfuge">aired</a>&nbsp;Dec.&nbsp;8, 2013, on Fox, a unit of Fox Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fox#NASDAQ">FOX</a>). The episode was part of season 25&nbsp;and 537th overall episode of the series.&nbsp;
Among the plotlines in the episode was Krusty the Klown going broke. Lisa Simpson encourages him to sell the foreign rights to his show for broadcasts in other countries.
&ldquo;Krusty are you broke?&rdquo; Lisa asks.
&ldquo;Yeah all it takes is some bad luck at the ponies, worse luck in the Bitcoin market, heavy investment in a high-end bookmark company,&rdquo; Krusty says.
The exchange is featured in a <a href="https://twitter.com/JonErlichman/status/1403744154262421506">tweet </a>from Jon Erlichman, who regularly tweets on business history and stocks.
<blockquote class="twitter-tweet">The first time Bitcoin was mentioned on The Simpsons was in 2013.
One Bitcoin then was worth $890. <a href="https://t.co/lri2ugTIul">pic.twitter.com/lri2ugTIul</a>
&mdash; Jon Erlichman (@JonErlichman) <a href="https://twitter.com/JonErlichman/status/1403744154262421506?ref_src=twsrc%5Etfw">June 12, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Related Link:<a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21378968/if-you-invested-1-000-in-dogecoin-amc-and-gamestop-on-jan-1-heres-how-much-youd-have-now"> If You Invested $1,000 In Dogecoin, AMC And GameStop On Jan. 1, Here&rsquo;s How Much You&rsquo;d Have Now</a>
Investing In Bitcoin After Simpsons Episode: If a viewer of &ldquo;The Simpsons&rdquo; was so enticed to invest in Bitcoin following the comment from Krusty the Klown, they would have done quite well.
On Dec. 8, 2013, Bitcoin had an average price of $795.87 according to <a href="https://coinmarketcap.com/historical/20131208/">CoinMarketCap</a>.
A $1,000 investment in Bitcoin on that day would have bought 1.2565 Bitcoins. That same 1.2565 Bitcoins would be valued at $48,521.05 on June 17, 2021, based on the current $38,616.04 price of Bitcoin.
Not a horrible return for watching one of the most beloved animated comedies of all time.

Education

If You Invested $1,000 In Bitcoin When 'The Simpsons' First Mentioned, Here's How Much You'd Have Now

Prince Harry and Meghan Markle welcomed the birth of their second child on June 4. The birth is causing controversy in England and has also changed the British royal family tree and order of succession behind Queen Elizabeth II.
What Happened: Since 1952, Elizabeth II has served as the Queen of England. The 95-year-old is the longest-serving Queen of the country with 69 years in the role. 
The order of the succession to Queen Elizabeth II has changed many times since her entry into the role as children, grandchildren&nbsp;and great-grandchildren are born.
After Prince Harry, the second oldest child of Prince Charles, and Meghan Markle welcomed their daughter Lilibet Diana Mountbatten-Windsor to the world, the top 10 people in order behind Queen Elizabeth II changed&nbsp;again.
The name selection of Lilibet, a childhood nickname of Queen Elizabeth II, has also led to some <a href="https://www.benzinga.com/news/21/06/21512924/prince-harry-and-meghan-threaten-bbc-with-lawsuit-over-report-on-naming-baby-lilibet-report">controversy </a>in the country over the usage of the name without permission.
Related Link: <a href="https://www.benzinga.com/news/21/06/21512924/prince-harry-and-meghan-threaten-bbc-with-lawsuit-over-report-on-naming-baby-lilibet-report">Prince Harry And Meghan Threaten BBC With Lawsuit Over Report On Naming Baby Lilibet</a>
Order of Succession: Since 1952, Queen Elizabeth&rsquo;s oldest son Prince Charles has been the heir apparent and that position has remained unchanged. Here is a look at the <a href="https://www.royal.uk/succession">order of succession</a> led by 72-year-old Charles.
<ul>
<li>Prince Charles, Prince of Wales, oldest child of Queen Elizabeth II and Prince Philip, Duke of Edinburgh</li>
<li>Prince William, Duke of Cambridge, oldest child of Prince Charles and Diana, Princess of Wales (Diana Spencer)</li>
<li>Prince George of Cambridge, oldest child of Prince William and Catherine, Duchess of Cambridge (Kate Middleton)</li>
<li>Princess Charlotte of Cambridge, second oldest child of Prince William and Duchess of Cambridge</li>
<li>Prince Louis of Cambridge,&nbsp;third oldest child of Prince William and Duchess of Cambridge</li>
<li>Prince Harry, Duke of Sussex, second oldest child of Prince Charles and the Princess of Wales</li>
<li>Archie Mountbatten-Windsor, oldest child of Prince Harry and Meghan, Duchess of Sussex&nbsp;(Meghan Markle)</li>
<li>Lilibet Diana Mountbatten-Windsor, second oldest child of Prince Harry and the Duchess of Sussex</li>
<li>Prince Andrew, second oldest child of Queen Elizabeth II and Prince Philip</li>
<li>Princess Beatrice, oldest child of Prince Andrew, Duke of York&nbsp;and Sarah, Duchess of York (Sarah Ferguson)</li>
</ul>
The birth of Lilibet has knocked Prince Andrew and his children, including his youngest, Princess Eugenie,&nbsp;down the list in the succession to Queen Elizabeth II.
Lilibet&rsquo;s birth has also moved Princess Anne to 16th place on the list. Anne is the second-born child and only daughter to Queen Elizabeth II.
(Image by&nbsp;<a href="https://pixabay.com/users/wikiimages-1897/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=63006">WikiImages</a>&nbsp;from&nbsp;<a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=63006">Pixabay</a>)

Politics

British Royal Family Tree: New Order Of Succession With Birth Of Lilibet

Stacks (STX) aims to bring smart contracts and decentralized applications, or DApps, to <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/" style="text-decoration-line:none">Bitcoin</a> (CRYPTO: BTC).&nbsp;An attractive facet for some is the ability to earn BTC earning through a mechanism the project calls &ldquo;Stacking.&rdquo;&nbsp; Mitchell Cuevas, Head of Growth at the Stacks Foundation sheds light on building on Bitcoin blockchain and other aspects of Stacks.
From Lump Of Gold To Active Asset: &ldquo;Stacks turns Bitcoin from being a passive asset into an active asset that is programmable and available to all,&rdquo; said Cuevas.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/04/20513415/stacks-stx-crypto-has-surged-3792-in-a-year-what-is-going-on" style="text-decoration-line:none">Stacks (STX) Crypto Has Surged 3792% In A Year &mdash; What Is Going On?</a>
Dismissing the ongoing narrative that deifies Bitcoin as &ldquo;digital gold&rdquo; or as a store of value, Cuevas says such an understanding persists &ldquo;because it&rsquo;s easier for people to assign analogies and comparisons.&rdquo;&nbsp;
<blockquote>&ldquo;That paradigm seems to be shifting already as leaders in the space continue to argue that Bitcoin is, in fact, &#39;not a rock&#39; like gold is, but a powerful, programmable technology, with a market worth over $1 trillion,&rdquo; said Cuevas.
</blockquote>
Cuevas says that Satoshi Nakamoto&nbsp;&mdash; the pseudonymous creator of Bitcoin &mdash;&nbsp; themselves did not limit the vision of the apex cryptocurrency as a &ldquo;store of value.&rdquo;
He said instead Nakamoto believed that new apps and chains would share Bitcoin&rsquo;s computing power.
Dealing With Roadblocks: Building on Bitcoin faces challenges that are evolving with time, as per Cuevas. A year ago tooling would have been a considerable challenge, but today, awareness and Bitcoin&rsquo;s PR problem are the latest impediments.
<blockquote>Cuevas told Benzinga that while a &ldquo;ton of great experimentation&rdquo; and activity is taking place on Ethereum (CRYPTO: ETH) or EVM-based chains because of familiarity with networks, developers are also increasingly aware of similar possibilities on Bitcoin. &ldquo;Many will look at some of the advantages of building there and you&rsquo;ll see the activity grow.&rdquo;
On the ongoing energy debate, brought into the public consciousness and the news reports by Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21096462/breaking-tesla-suspends-vehicle-purchases-via-bitcoin-over-environmental-concerns" style="text-decoration-line:none">stopping BTC payments</a>,&nbsp; Cuevas said it was &ldquo;oversimplified and blown out of proportion.&rdquo;
</blockquote>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21098323/elon-musk-says-tesla-looking-at-other-cryptos-who-use-less-than-1-of-bitcoins-energy-which" style="text-decoration-line:none">Elon Musk Says Tesla &#39;Looking At&#39; Other Cryptos That Use Less Than 1% Of Bitcoin&#39;s Energy. Which Could Be It?</a>
&ldquo;No one wants to feel like they&rsquo;re contributing to something that is bad for the environment. So, the community certainly needs to deal with that and there are several good efforts to that end,&rdquo; said Cuevas.
Battle-Tested Technology: Despite the bad rap on the environment, Stacks plans to stick to Bitcoin because it is the &ldquo;most secure, most battle-tested blockchain available.&rdquo; Cuevas said that Stacks actually reuses electricity already burned to secure Bitcoin.
Referring to the Proof of Transfer (PoX) mining mechanism used by Stacks, Cuevas said Stacks approached the environmental concerns by efficiently using resources made available by Bitcoin&rsquo;s network.
He said Stacks mainly operates by &ldquo;recycling the energy to be reused to secure our chain and chains on top of Stacks without the need to run [Proof of Work] again.&rdquo;
Proof of Work is the mining mechanism used by Bitcoin that requires solving complex mathematical puzzles, which in turn require power-hungry computing resources.
See Also: <a href="https://www.benzinga.com/money/proof-of-stake-vs-proof-of-work/" style="text-decoration-line:none">Proof Of Stake Vs Proof Of Work</a>
<blockquote>Cuevas pointed out that PoX can work with other blockchains as well and if there was a better option than Bitcoin for a settlement layer &ldquo;chains could migrate accordingly.&rdquo; &ldquo;That said, we don&rsquo;t see that as being very likely.&rdquo;
</blockquote>
Why Stacking Is Bae: Stacks users can lock up their STX and earn BTC in a process calling Stacking. This according to Cuevas has received a great reaction.&nbsp;
&ldquo;We have surpassed $330M in [Total Value Locked] for Stacking, which puts us in the Top 25 in terms of TVL for DeFi projects at just about 5 months in,&rdquo; said Cuevas.&nbsp;&nbsp;
At press time, STX traded 4.79% lower at $0.90 over 24 hours. The cryptocurrency traded 0.86% lower against Bitcoin (BTC). BTC traded 3.77% lower at $38,774.15 in the same time frame.
<blockquote>Since the year began, STX has soared 125%. Stacks TVL at press time was $350.21 million, as per CoinMarketCap data.
</blockquote>
Cuevas revealed that new Stacking providers have come online and they are starting to see the first wave of businesses start to experiment with integrating Stacking into their business models.&nbsp;
Benzinga asked Cuevas if high Bitcoin fees were a barrier to Stacking, to which he replied, &ldquo;We haven&rsquo;t seen it yet, at over 10% APY, the yield is so good I don&rsquo;t think it&rsquo;s been a problem. We&rsquo;re also working on some improvements in how Stacking pays out to reduce fees in the future.&rdquo;
Popular Like A K-Pop Idol? In April, OkCoin Chief Operating Officer Jason Lau told Benzinga that STX doubled in value less than 24-hours after it became <a href="https://www.benzinga.com/markets/cryptocurrency/21/04/20513415/stacks-stx-crypto-has-surged-3792-in-a-year-what-is-going-on" style="text-decoration-line:none">available to trade</a> on a South Korean exchange.&nbsp;
The credit for the popularity goes to local community management and tight regulations in Korea, as per Cuevas.
&ldquo;Stacks is the only asset to execute a Reg A sale with qualification from the SEC and has been transparent and careful throughout its journey. We believe this has made STX especially attractive to this local market.&rdquo;
Cuevas disclosed that Paycoin, a cryptocurrency platform, also integrated STX, thus allowing locals to use the cryptocurrency at vendors like 7-Eleven, KFC, Domino&rsquo;s Pizza, and others.
Making It Simple: Despite the learning curve involved in dealing with cryptocurrencies, Cuevas is hopeful that familiar interfaces such as wallets and web browsers can make it easier for the average person to use Stacks.
&ldquo;As far as the STX economy and Stacking, right now you can jump on Okcoin and go from having no STX to Stacking in a few clicks,&rdquo; said Cuevas.
&ldquo;One of our priorities is increasing STX token access around the world so we are supporting integrations and infrastructure for Stacks that make it easier for people to interact with everything the network has to offer and participate in a way that makes sense and provides them with value.&rdquo;
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/21/06/21600279/now-is-the-right-time-for-new-investors-to-buy-bitcoin-says-pantera-ceo" style="text-decoration-line:none">Now Is The Right Time For New Investors To Buy Bitcoin, Says Pantera CEO</a>

Interview

$ETH

$STX

EXCLUSIVE: Building On Top Of Bitcoin May Not Be As Popular As Ethereum, Other Blockchains, But We're 'Close To Seeing Some Runaway Success,' Says Stacks

Tesla Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) CEO Elon Musk, whose net worth has immensely benefited from the green energy trend, faces stiff competition from Indian billionaire Gautam Adani.
What Happened: A rapid rise in the stocks of companies controlled by Adani has catapulted the tycoon to the spot of Asia&rsquo;s second-richest person behind compatriot Mukesh Ambani. Adani is the chairman and founder of the power-to-ports conglomerate Adani Group.
According to the <a href="https://www.bloomberg.com/billionaires/?sref=TBDibEcD">Bloomberg Billionaires Index</a>, Adani is now the 14th richest person with a net worth of $73.1 billion, just two places behind compatriot Ambani who has a net worth of $86.5 billion. Musk, with a net worth of $171 billion, stands third on the list.
Adani has added record wealth this year, next only to&nbsp;LVMH Moet Hennessy Louis Vuitton SA&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/lvmuy#OTC">LVMUY</a>) CEO Bernard Arnault. This is despite a recent rout in stocks of his companies fueled by a <a href="https://economictimes.indiatimes.com/markets/stocks/news/a/cs-of-3-fpis-owning-adani-shares-frozen/articleshow/83496483.cms">report</a> that&nbsp;India&rsquo;s national share depository froze accounts of 3&nbsp;Foreign Portfolio Investors that had stakes in Adani Group.
See also: <a href="https://www.benzinga.com/money/how-to-buy-tesla-stock/">How to Invest in Tesla Stock</a>
AGEL Boost: Adani even beat the gains for Berkshire Hathaway Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brk-a#NYSE">BRK-A</a>) (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brk-b#NYSE">BRK-B</a>) chairman Warren Buffett, and Ambani for the biggest growth in wealth this year, according to a <a href="https://www.bloombergquint.com/business/a-43-billion-jump-in-adani-s-fortune-is-fraught-with-many-risks">report</a> by Bloomberg. His net worth got a major boost from a 354.8% gain by Adani Green Energy Green Limited (AGEL), a renewable energy company, over the past year.
Political Backing: Like Ambani, Adani has long been a vocal supporter of India&rsquo;s Prime Minister Narendra Modi. A <a href="https://www.ft.com/content/474706d6-1243-4f1e-b365-891d4c5d528b">report</a> by the Financial Times in November last year had noted that critics feel Adani&rsquo;s rise is symbolic of a system where too much power is in the hands of too few.
Why It Matters: AGEL, one of the largest renewable companies in India with a current project portfolio of 13,990 MW, has said it plans to become the world&rsquo;s largest solar player by 2025 and the world&rsquo;s largest renewable company by 2030.
In May, AGEL said its acquisition of SoftBank Group Corp. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/sftby#OTC">SFTBY</a>)-backed SB Energy Holdings Limited for an enterprise value of about $3.5 billion will enable it to achieve its target renewable portfolio of 25 GW four years ahead of the target timeline. The acquisition is the largest in the renewable energy sector in India.
While Adani has done well at home, his controversial Carmichael coal mine in Australia has faced intense criticism from environmentalists.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/05/21209659/tesla-could-find-an-even-bigger-market-in-india-than-china-says-analyst">Tesla Could Find An Even Bigger Market In India Than China, Says Analyst</a>
Tesla In India: Tesla has recently made several moves as part of its plan to enter the Indian market, including hiring <a href="https://www.benzinga.com/news/21/04/20533520/tesla-ramps-up-india-plan-as-it-onboards-exec-to-lead-business-and-lobbying-report">local talents</a> to oversee its operations in the country. India&rsquo;s huge market holds similar potential for Tesla as China does.
It was <a href="https://www.benzinga.com/news/21/04/20793211/tesla-chooses-mumbai-for-first-office-showroom-in-india-report">reported</a> in April that Tesla is planning to open its first showroom and an office in Mumbai, India&rsquo;s financial capital.
The Palo Alto-based company has already registered its headquarters in the southern Indian city of Bengaluru.
Photo by <a href="https://commons.wikimedia.org/wiki/File:Gautam_Adani_Net_Worth.jpg">Chirag200201</a> on Wikimedia

BRK-A

BRK-B

LVMUY

SFTBY

Think Elon Musk Is Getting Rich On The Green Energy Trend? Meet Indian Billionaire Gautam Adani

High Tide Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hiti#NASDAQ">HITI</a>) shares climbed higher Friday on continued momentum after the company announced Thursday it would release its financial and operational results for Q2 of 2021 after market close on June 28, 2021.
Friday the stock was&nbsp;trending on social media sites such as StockTwits throughout the day.
High Tide was up 5.63% at $7.50&nbsp;at last check on Friday afternoon.
<img alt="hitidaily6-18-21.png" src="https://www.benzinga.com/files/u285825/hitidaily6-18-21.png" style="height:400px; width:640px" />
<h3>High Tide Daily Chart Analysis:</h3>
<ul>
<li>Shares were falling the past few months, and are forming into what technical traders call a falling wedge pattern.</li>
<li>The stock is trading below the 50-day moving average (green), but above the 200-day moving average (blue), indicating the stock is likely in a period of consolidation.</li>
<li>The 50-day moving average may hold as an area of resistance, while the 200-day moving average is somewhere the stock may find support.</li>
</ul>
<h3>Key Levels To Watch:</h3>
<ul>
<li>The stock is trading within a falling wedge pattern and may not see a breakout for the next couple of months, unless there is a catalyst making&nbsp;the stock move.</li>
<li>The falling wedge pattern is a bullish reversal pattern that happens after the stock makes a large run up and starts pulling back. The slope of the line connecting the highs is much steeper than the line connecting the lows.</li>
<li>The Relative Strength Index (RSI) has been falling throughout the past couple of weeks and is now starting to see a bounce. The RSI sat at 37 Thursday, and Friday climbed back higher to 43 becoming less oversold.</li>
</ul>
<h3>What&rsquo;s Next?</h3>
Bullish technical traders would like to see the stock continue to trade within the falling wedge pattern and head toward the pattern resistance. Stocks that stay near pattern resistance while trading within a pattern are more likely to break out.
Bulls would also like to see the stock cross above 50 on the RSI because above 50 on the indicator means that there are more buyers than sellers.
Bearish technical traders would like to see the stock fall below the pattern support. If the stock fell below the pattern support and was able to hold below this level, then the stock may see a stronger downward push. Bears would also like to see the RSI drop further and fall below 30.
(Image by&nbsp;<a href="https://pixabay.com/users/ganjaspliffstoreuk-21312000/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=6203937">Ganja Spliff</a>&nbsp;from&nbsp;<a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=6203937">Pixabay</a>)

Cannabis

Long Ideas

Short Ideas

Technicals

HITI

High Tide Stock Could See A Breakout In The Coming Weeks: Here's Why

One of the largest beverage companies in the world could be launching products&nbsp;to take part in one of the fastest-growing beverage categories, hard seltzers.
What Happened: A filing by PepsiCo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pep#NYSE">PEP</a>) on June 14 is seeking to use the Rockstar name for beer and hard seltzer, <a href="https://www.bloomberg.com/news/articles/2021-06-18/pepsi-seeks-trademark-for-rockstar-branded-beer-hard-seltzer?sref=TBDibEcD">Bloomberg </a>reports.
The move follows the company saying on its third-quarter earnings call that it was exploring alcoholic drinks and would &ldquo;make a decision in the coming quarters.&rdquo;
There has been no official announcement from PepsiCo at this time in regards to alcoholic beverages.
Related Link: <a href="https://www.benzinga.com/trading-ideas/long-ideas/21/01/19283702/stock-wars-coca-cola-vs-pepsi">Stock Wars: Coca-Cola Vs. Pepsi</a>
Why It&rsquo;s Important: Sales of hard seltzers have rocketed to one of the fastest-growing alcoholic beverages. Hard seltzer sales were $500 million in 2018 and hit over $4 billion in 2020, according to the <a href="https://www.nytimes.com/2021/05/30/business/white-claw-hard-seltzer-sales.html">New York Times</a>.
One of the top-selling hard seltzer brands is Truly, which has helped shares of Boston Beer Company Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>) post a five-year return of 508%, with much of that coming in the last two years.
Pepsi&rsquo;s largest beverage rival Coca-Cola Co&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>) has a <a href="https://www.benzinga.com/news/20/09/17701651/molson-coors-continues-hard-seltzer-push-with-coca-cola-topo-chico-deal">partnership </a>with Molson Coors Beverages Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tap#NYSE">TAP</a>) for a hard seltzer version of Topo Chico, which was a mineral brand acquired by Coca-Cola in 2017.
Beverage industry research firm IWSR expects hard seltzer consumption to triple by 2023.
PEP Price Action: Shares of PepsiCo are down 2.09% to $145.42&nbsp;on Friday. Shares have traded between $128.05 and $149.27 over the last 52 weeks.
(Image by&nbsp;<a href="https://pixabay.com/users/stevepb-282134/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=907124">Steve Buissinne</a>&nbsp;from&nbsp;<a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=907124">Pixabay</a>)

Watch Out Truly, Pepsi Could Be Launching A Hard Seltzer Soon

This article by Jackie Bryant was originally published on&nbsp;<a href="http://Weedmaps.com/news/">Weedmaps</a>, and appears here with permission.
When it comes to celebrity cannabis brands, not all are created equal.&nbsp;
Many celebrities who have ventured into the cannabis industry just white label their products, meaning that they pay another company to produce the product and just slap their name on it and call it a day. Others have waded a bit deeper into the waters, getting involved in grower and strain selection, as well as having a say in marketing initiatives and other product launches.&nbsp;
But by buying land in Oregon and becoming a cannabis farmer, Jim Belushi has taken his passion for cannabis even further than other celebrities and big names with his cannabis brand,&nbsp;<a href="https://www.belushisfarm.com/" rel="noreferrer noopener" target="_blank">Belushi&#39;s Farm</a>.
&ldquo;I love this cannabis world,&rdquo; Belushi said during a phone interview while filming in Pasadena. &ldquo;I&#39;m a magic chaser &mdash; there&#39;s magic on Broadway, in music with the Blues Brothers, in the movies and TV, and magic in the cannabis industry.&rdquo;
Belushi is probably most widely known as an actor and comedian with roles in television series&nbsp;Saturday Night Live&nbsp;and&nbsp;According to Jim, and dozens of feature films. He started his cannabis journey when he purchased Oregon farmland that became available in 2015. He planted 48 plants under the state&#39;s medical marijuana program. &ldquo;It was a rebirth, a reinvention,&rdquo; he said, &ldquo;I just kind of fell into it.&rdquo;
Today, Belushi&#39;s Farm products can be found in Oregon, Colorado, and Illinois, with many more to come.&nbsp;
<blockquote class="twitter-tweet">Watch the latest <a href="https://twitter.com/hashtag/GoodCompany?src=hash&amp;ref_src=twsrc%5Etfw">#GoodCompany</a> with comedic legends <a href="https://twitter.com/JimBelushi?ref_src=twsrc%5Etfw">@JimBelushi</a> and <a href="https://twitter.com/dan_aykroyd?ref_src=twsrc%5Etfw">@dan_aykroyd</a> and catch Jim&#39;s new show &quot;Growing Belushi&quot; tonight at <a href="https://t.co/CkEwayB3Nc">https://t.co/CkEwayB3Nc</a> <a href="https://t.co/jzaBDfMYnb">pic.twitter.com/jzaBDfMYnb</a>
&mdash; Live Nation (@LiveNation) <a href="https://twitter.com/LiveNation/status/1296129805360930816?ref_src=twsrc%5Etfw">August 19, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Belushi&#39;s path was documented in a documentary series called&nbsp;<a href="https://www.discovery.com/shows/growing-belushi" rel="noreferrer noopener" target="_blank">Growing Belushi</a>, which first aired on Discovery in 2020. The series chronicles the actor and his team&#39;s efforts to build a legal cannabis operation, including the growing apparatus, from scratch. He isn&#39;t able to say whether or not there will be a season two, but he hinted that it looks promising.
The documentary also goes into the emotional side of Belushi&#39;s exploration of cannabis. He credits the plant with helping him on his own journey, saying, &ldquo;hell yeah it [helps]! These ladies lead you where you&#39;re supposed to go.&rdquo; Having suffered the loss of his brother John to an overdose, he is a proponent of cannabis&#39;s beneficial properties across a spectrum of uses, but most notably in treating trauma.&nbsp;
<img alt="Jim Belushi Growing Belushi" src="https://weedmaps.com/news/wp-content/uploads/2021/05/Copy-of-Jim_Belushi_004da-2-1024x576.jpg" style="height:351px; width:624px" />
He remembered a time when he was doing a promotional dispensary visit, and he caught eyes with a &ldquo;skinny, long-haired, blue-eyed man&rdquo; who ended up approaching him.
&ldquo;He said, &#39;You know, I was a medic in Iraq and I saw things that happened to the human body that nobody should ever witness. I have, they call it, triple PTSD. They gave me a bottle of 600 Oxycontin and I couldn&#39;t do it. I couldn&#39;t talk to my children or my wife, I couldn&#39;t sleep at night. I started smoking cannabis, your strain Black Diamond OG, and it&#39;s the only thing that allows me to talk to my wife and my kids. Now I can sleep,&#39;&rdquo; Belushi shared of his encounter. &ldquo;He teared up and hugged me &hellip; That was a paradigm shift for me. It&#39;s not about money anymore, it&#39;s about creating a safe pathway for people to use.&rdquo;
<h3>Jim Belushi&#39;s favorite weed</h3>
Belushi said he&#39;s used more cannabis than ever during the pandemic, which has helped in &ldquo;fighting off depression and anxiety like Richard Dreyfuss fought off Jaws.&rdquo;&nbsp;<a href="https://weedmaps.com/learn/products-and-how-to-consume/how-to-microdose-cannabis?utm_source=Braze&amp;utm_medium=email&amp;utm_campaign=newsletter&amp;utm_content=Learn" target="_self">He credits microdosing</a>, which he considers to be a low-dose edible or &ldquo;one-and-a-half hits off a joint&rdquo; with keeping the blues at bay. &ldquo;It really helps me mitigate that sadness of what&#39;s going on in the world and the sadness that comes into your life by just trying to survive through this year.&rdquo;
Below, check out five essential weed products that Jim Belushi can&#39;t live without.
<h3>Bhang Chocolates</h3>
&ldquo;It&#39;s really the best one. I take 2.5 - 5 milligrams to help me sleep,&rdquo; Belushi said.&nbsp;
Any in particular? &ldquo;Any of &#39;em! It&#39;s because of the way they blend it. I also think the difference between a gummy and a chocolate is the gummy is filled with more refined sugar &mdash; I take the same amount of a gummy as I would a chocolate and my dreams are full of color and explosion and I&#39;m like, &#39;Whoa, I&#39;m high!&#39;&rdquo; he said while laughing.
&ldquo;With chocolates, I think it&#39;s because of the fat content, for some reason I just believe, I have no proof, but I think it mellows out the THC in combination with the sugar. It&#39;s not an active high, but peaceful, and I sleep all night.&rdquo;&nbsp;
<h3>Cherry Pie</h3>
&ldquo;I have a strain called&nbsp;<a href="https://www.belushisfarm.com/product-page/cherry-pie" target="_blank">Cherry Pie</a>&nbsp;that we call &#39;The Marriage Counselor,&#39;&rdquo; Belushi said. It&#39;s a cross between Granddaddy Purple and Durban Poison.
&ldquo;It&#39;s only about 19% THC and it&#39;s got a great terpene profile: 3%. That entourage effect just chills me like a glass of wine used to. I&#39;m more charming, I&#39;m still articulate, and I actually listen! The great thing about Cherry Pie is that nobody can tell you smoked it.&rdquo; He&nbsp; mentioned that his wife doesn&#39;t even notice his sudden pleasant demeanor after toking up.
<h3>Blues Brothers .25 gram mini-joints</h3>
&ldquo;We have these little &#39;mama&#39;s helpers,&#39; we call &#39;em, these little 2.5-milligram shorties,&rdquo; Belushi said. &ldquo;This is the&nbsp;<a href="https://www.belushisfarm.com/product-page/the-blues-brothers-25-mini-packs" target="_blank">Blues Brothers pack</a>. Baby Blues. There&#39;s six of &#39;em. It&#39;s a parking lot joint before a movie.&rdquo;
&ldquo;I smoke those little teeny joints because I&#39;m such a lightweight &hellip; Our Baby Blues fly off the shelves. People love them because they&#39;re tasty and small, they&#39;re perfect for Covid, as opposed to sharing a joint. I don&#39;t think people want to get that high, they just want to chill,&rdquo; he said of why the dose is perfect, in his opinion. &ldquo;It&#39;s like having a cocktail at night except for a whole bottle of wine.&rdquo; The strains vary from state-to-state.
<h2>Captain Jack distillate vape cartridges</h2>
&ldquo;We made a collaboration with&nbsp;<a href="https://selectcannabis.com/" target="_blank">Select</a>, and man, do they know what they&#39;re doing there,&rdquo; Belushi said of his vape cartridges made with the Captain Jack strain, which was first made popular thanks to Saturday Night Live. The strain is potent at 21 - 25% THC and is&nbsp;<a href="https://weedmaps.com/learn/the-plant/myrcene" target="_self">loaded with the terpene myrcene</a>,&nbsp; which has a peppery taste and a sedative effect that comes through in the vape oil.
The strain is named for&nbsp;<a href="https://www.belushisfarm.com/captain-jack" target="_blank">Jack Murtha, known as &quot;Captain Jack,&quot;</a>&nbsp;who is a pioneer of cannabis cultivation. He spent more than 40 years perfecting his namesake strain, based on Gulzar Afghanica, which he first encountered in 1971 during a hot summer in the valley of the Kush Mountains in Afghanistan. Learning the Afghani process for cultivating the plant, Captain Jack was gifted seeds by the village elders and he&#39;s been growing the pure landrace strain from seed to flower ever since. It has never been tweaked nor compromised, Belushi said &ldquo;This strain is best known as the &ldquo;Smell of SNL.&#39;&rdquo;&nbsp;
Though it&#39;s a bit too strong for him for regular use, he noted, &ldquo;I take one little hit and I&#39;m very creative and funny. It&#39;s good for writing. You take a few more and it&#39;s good for communication and then you&#39;re out,&rdquo; adding that it&#39;s a totally different experience from Cherry Pie.
<h3>Belushi growing kit</h3>
Coming &ldquo;sometime later this year,&rdquo; is the Belushi Growing Kit, which will be sold in collaboration with&nbsp;<a href="https://growgeneration.com/" target="_blank">GrowGeneration</a>.
&ldquo;I&#39;m working with GrowGeneration, which is a really great company,&rdquo; he said of the hydroponic and organic growing company. &ldquo;They have 52 stores across the country. I&#39;m working with them to put a kit together to teach people how to grow at home.&rdquo; The kit will include a lightbox, tent, LED light, and soil with certain nutrients used on Belushi&#39;s Farm. There will also be pruning and trimming instructions and more.
Belushi became inspired to launch a grow kit thanks to his own growing experience, which he said &ldquo;grounded&rdquo; him and brought him &ldquo;closer to Mother Earth.&rdquo; He hopes to be able to bring that sensation to would-be cannabis home-growers across the United States.
Photos courtesy of Zoe Wilder. Featured graphic by David Lozada/Weedmaps
Read the original article on <a href="https://weedmaps.com/news/2021/05/5-weed-products-jim-belushi-cant-live-without/">Weedmaps.</a>
<a href="https://benzinga.com/cannabis/" rel="noopener noreferrer" target="_blank">Benzinga</a>&#39;s Related Links:&nbsp;
<ul>
<li><a dir="ltr" href="https://www.google.com/url?client=internal-element-cse&amp;cx=005794925877256802002:ckazbf3vrxs&amp;q=https://www.benzinga.com/markets/cannabis/20/08/16994239/the-best-weed-strains-for-arousal-according-to-cannabis-and-sex-experts&amp;sa=U&amp;ved=2ahUKEwjyzqXdsvfwAhWwIrkGHT50BV8QFjADegQIABAC&amp;usg=AOvVaw1sQgliGVb0XrIsH5cUgKvT" target="_blank">The Best Weed&nbsp;Strains&nbsp;For Arousal</a></li>
<li><a dir="ltr" href="https://www.google.com/url?client=internal-element-cse&amp;cx=005794925877256802002:ckazbf3vrxs&amp;q=https://www.benzinga.com/markets/cannabis/20/11/18200475/the-best-cannabis-strains-of-all-time-according-to-experts&amp;sa=U&amp;ved=2ahUKEwjyzqXdsvfwAhWwIrkGHT50BV8QFjAFegQICRAC&amp;usg=AOvVaw2nntvbSEQg2YL30uKuTJs0" target="_blank">The Best Cannabis&nbsp;Strains&nbsp;Of All Time, According To Experts</a></li>
<li>M&aacute;s de&nbsp;<a href="https://elplanteo.com/author/weedmaps/">Weedmaps</a>&nbsp;en espa&ntilde;ol en El Planteo</li>
</ul>

5 Weed Products Jim Belushi Can't Live Without

Atai Life Sciences (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>), a biotech company in the psychedelic space, had its Nasdaq debut on Friday.
The Berlin-based company is joining an exclusive group of start-ups in the psychedelics sector to IPO this year on the Nasdaq, including MindMed (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) and Compass Pathways (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmps#NASDAQ">CMPS</a>).
Initially founded as a holding group that later became involved in operations, Atai handles a growing portfolio of about 12 companies, all focused on bringing novel mental health treatments through the use of various disruptive technologies and molecules including psychedelic medicines.
Its portfolio includes Perception Neurosciences, a company putting ketamine through clinical trials for the treatment of depression, as well as other companies developing psychedelics like&nbsp; MDMA, ibogaine and DMT for mental health purposes.
Atai is also a major shareholder in Compass Pathways, a company developing psilocybin products for psychedelics-assisted psychotherapy, which was the first psychedelics company to <a href="https://www.benzinga.com/markets/cannabis/20/09/17571756/mind-medicine-ceo-calls-compass-ipo-a-clear-bellwether-for-psychedelic-space">debut on Wall Street in September 2020</a>.
Largely focused on drug development, Atai&rsquo;s revenue stream is still dependent on the regulatory approval of the compounds and treatments in its pipeline. As of now, molecules and treatments under Atai&rsquo;s wing are still going through different stages of development from discovery to Phase II clinical trials.
Backed by PayPal (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pypl#NASDAQ">PYPL</a>) founder Peter Thiel, the company had raised over $362 million since its inception in 2018. Atai raised an additional $225 million from its upsized initial public offering on Thursday, selling 15 million shares at a price of $15.
Price Action: Atai stock opened trading at $21, giving the company&nbsp;a market valuation of about $3.19 billion.
The stock peaked at about $22 before noon&nbsp;and reached a low-end point of $16.50 to close its first day of trading at $19.45.
Photo by lo lo on Unsplash

Penny Stocks

Small Cap

ATAI

CMPS

MNMD

PYPL

Peter Thiel-Backed Psychedelics Company Rings Nasdaq Bell: Atai Life Sciences Goes Public

The highly anticipated 2020 Summer Olympics in Tokyo are set to premiere in July after a COVID-19 related delay.
The Summer Olympics could mean big money for NBC and its parent company Comcast Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NASDAQ">CMCSA</a>).
What Happened: At a recent <a href="https://www.bloomberg.com/news/articles/2021-06-14/nbc-says-olympics-may-be-most-profitable-ever-despite-pandemic?sref=TBDibEcD">presentation</a>, NBC said the upcoming 2020 Summer Olympics (July 23 to Aug. 8)&nbsp;could be the most profitable for the company.
&ldquo;Depending on how ratings are, it could be our most profitable Olympics in the history of the company, NBCUniversal CEO Jeff Shell said.
Prior to the pandemic, the company had sold $1.25 billion in advertisements, seeing strong demand from many sectors. The interest&nbsp;is due to many of the U.S. Olympians favored in their events and sports, which could help with strong viewership.
NBC plans more than&nbsp;7,000 hours of programming for broadcast, cable and its Peacock streaming platform.
The Peacock streaming platform for NBC will also <a href="https://variety.com/2021/tv/news/peacock-docuseries-female-olympians-96-games-1234997372/">launch </a>coverage of some of the best female Olympians from the 1996 Summer Olympics. This includes &ldquo;The &rsquo;96 Effect,&rdquo; a three-part docuseries following women who won gold medals.
Peacock will also stream the U.S. Women&rsquo;s National Soccer Team final game, which has never been televised, alongside &ldquo;The Sisters of &rsquo;96: The 1996 USA Women&rsquo;s Soccer Olympic Team,&rdquo; which will reunite some of the soccer stars to watch the match together.
Related Link:<a href="https://www.benzinga.com/news/21/03/20079372/why-comcast-could-be-ready-to-cash-in-on-hulu-stake-with-disney"> Why Comcast Could Be Ready To Cash In On Hulu Stake With Disney</a>
Why It&rsquo;s Important:&nbsp;NBC <a href="https://nbcsportsgrouppressbox.com/2016/08/22/nbcs-rio-olympics-is-the-most-successful-media-event-in-history/">called </a>the 2016 Summer Olympics the most successful media event in history with $250 million in profit for the company.&nbsp;
An average of 27.5 million people tuned into Primetime Olympics coverage in 2016, representing the second-highest primetime audience for any non-U.S. Summer Olympics. Records were set for the 18 to 34 and 18 to 49 adult demographics in 2016. Seventy-eight percent of U.S. homes tuned into NBC for Olympics coverage in 2016.
The inclusion of Olympics coverage on cable networks owned by Comcast also boosted their viewership, including NBCSN being the No. 1 sports cable network for primetime viewers over a 14-day period during the Olympics.
Comcast paid $4.4 billion for the U.S. rights to the Olympics from 2014 to 2020, representing around $1.1 billion per Olympics. The company&rsquo;s renewal for the Olympics rights from 2021 to 2032 was for $7.75 billion, representing $1.3 billion per Olympics.
The 2016 Olympics coverage from Comcast featured 6,755 hours of content, which is expected to be passed this year and could help viewer figures.
While the 2020 Summer Olympics will be missing several high-profile athletes such as&nbsp;Michael Phelps and Usain Bolt, it could see strong viewership for returning athletes like Simone Biles, Katie Ledecky and others.
&ldquo;Simone Biles is just amazing. She&rsquo;s going to be on every night and then our swimming team is really strong and our track and field team is really strong,&rdquo; Shell said.
The results from the Olympics along with the guidance of advertising demand could be keys&nbsp;to watch when Comcast reports second-quarter earnings in July and third-quarter results in October.
CMCSA Price Action: Shares of Comcast are down 1.41% to $56.71&nbsp;on Friday. Shares have traded between $37.77 and $59.11 over the last 52 weeks.
(Photo: Olympic Games)
&nbsp;

Global

CMCSA

Could The 2020 Olympics See Record Profits For Comcast?

<h3>GAINERS:</h3>
<ul>
<li><a href="https://quotes.benzinga.com/quote/CURR" target="_blank">CURE Pharmaceutical Hldg</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/curr#OTC">CURR</a>) shares closed up 11.45% at $0.73</li>
<li><a href="https://quotes.benzinga.com/quote/MRMD" target="_blank">MariMed</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mrmd#OTC">MRMD</a>) shares closed up 9.23% at $1.06</li>
<li><a href="https://quotes.benzinga.com/quote/KSHB" target="_blank">KushCo Holdings</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/kshb#OTC">KSHB</a>) shares closed up 6.56% at $0.92</li>
<li><a href="https://quotes.benzinga.com/quote/TBPMF" target="_blank">Tetra Bio Pharma</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/tbpmf#OTC">TBPMF</a>) shares closed up 5.85% at $0.28</li>
<li><a href="https://quotes.benzinga.com/quote/UGRO" target="_blank">Urban-gro</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ugro#NASDAQ">UGRO</a>) shares closed up 4.53% at $9.70</li>
<li><a href="https://quotes.benzinga.com/quote/BLOZF" target="_blank">Cannabix Technologies</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/blozf#OTC">BLOZF</a>) shares closed up 3.53% at $0.88</li>
<li><a href="https://quotes.benzinga.com/quote/TRSSF" target="_blank">TerrAscend</a>&nbsp;(OTC:&nbsp;<a class="ticker" href="https://www.benzinga.com/stock/trssf#OTC">TRSSF</a>) shares closed up 2.57% at $10.39</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://quotes.benzinga.com/quote/YCBD" target="_blank">cbdMd. Inc.</a>&nbsp;(AMEX:YCBD) shares closed down&nbsp;9.39% at $2.87</li>
<li><a href="https://quotes.benzinga.com/quote/BMMJ" target="_blank">Body and Mind</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/bmmj#OTC">BMMJ</a>) shares closed down 7.39% at $0.32</li>
<li><a href="https://quotes.benzinga.com/quote/IVITF" target="_blank">Invictus MD Strategies</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/ivitf#OTC">IVITF</a>) shares closed down 7.63% at $0.05</li>
<li><a href="https://quotes.benzinga.com/quote/ICNAF" target="_blank">Icanic Brands</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/icnaf#OTC">ICNAF</a>) shares closed down 6.69% at $0.25</li>
<li><a href="https://quotes.benzinga.com/quote/MMNFF" target="_blank">MedMen Enterprises</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mmnff#OTC">MMNFF</a>) shares closed down 6.23% at $0.26</li>
<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnvcf#OTC">CNVCF</a>) shares closed down 5.61% at $0.26</li>
<li><a href="https://quotes.benzinga.com/quote/VFF" target="_blank">Village Farms Intl</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) shares closed down 4.95% at $9.99</li>
<li><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ogi#NASDAQ">OGI</a>) shares closed down 4.28% at $2.91</li>
</ul>
<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real-time following this link.</a>
Lead image by Ilona Szentivanyi. Copyright: Benzinga.

After-Hours Center

BLOZF

BMMJ

CNVCF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

ICNAF

IVITF

KSHB

MMNFF

MRMD

TETRA BIO-PHARMA INC ORD by Tetra Bio-Pharma Inc.

TBPMF

TRSSF

UGRO

Cannabis Stock Gainers And Losers From June 18, 2021

Power tool company&nbsp;Stanley Black &amp; Decker Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/swk#NYSE">SWK</a>) CFO Donald Allan Jr is seeking partnerships with battery and chip manufacturers to ease the pressure on the tool maker&rsquo;s supply chain, the&nbsp;<a class="editor-rtfLink" href="https://www.wsj.com/articles/stanley-black-decker-cfo-looking-for-partnerships-with-battery-chip-makers-11624017600?mod=tech_lead_pos3" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Wall Street Journal reports</a>.
What Happened:&nbsp;The company is seeking electric battery and computer chip makers for component supply in return for an investment.
Stanley Black &amp; Decker has a tentative partnership with a South Korean battery maker for a production line that will start manufacturing batteries in Malaysia in 2022. It is also in talks with other Asian and U.S. businesses about potential partnerships.
Stanley Black &amp; Decker estimated $500 million in 2021 capital expenditures. It plans to incur about 10% - 15% of that to supply-chain partnerships and other related initiatives. Supply chain partnerships accounted for less than 5% of the CAPEX before the pandemic.
Stanley Black &amp; Decker already has small-scale partnerships with companies that build specific tooling and production lines.
The company needs batteries for its cordless power tools and uses computer chips across its portfolio. It manufactures a significant portion of its products in the U.S. and Europe. It prefers to set up new production lines in those regions to beat Asia&rsquo;s long wait times.
Why It Matters:&nbsp;SWK remains bullish on demand for its components like batteries and chips.
Competitors like Japan&rsquo;s&nbsp;Makita Corp&nbsp;(OTC:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/mktay#OTC" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">MKTAY</a>) and Hong Kong&rsquo;s&nbsp;Techtronic Industries Co Ltd&nbsp;(OTC:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/ttndy#OTC" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">TTNDY</a>) manufacture a more significant chunk of their products in Asia, potentially providing them with easier access to batteries and chips.
Stanley Black &amp; Decker identified around critical 30 suppliers and extended and prolonged contracts with many of them for up to five years.
Any price hike for batteries and chips can have a sizable impact on its finances as the components account for the most significant proportion of goods sold.
The company raised the cost guidance from $160 million to $235 million for 2021 due to inflation. It aims to pass two-thirds of the increase on to customers and offset the rest by increasing efficiency and cost savings.
Stanley Black &amp; Decker began raising prices for some of its products this quarter and has more hikes due.
The company expects to free up between $100 million and $150 million a year by increasing efficiency and cost savings.
Stanley Black &amp; Decker&rsquo;s Q1 operating margin expanded 810 basis points to 16.9%.
The company will need more batteries&nbsp;<a class="editor-rtfLink" href="https://ir.stanleyblackanddecker.com/news-releases/news-release-details/stanley-black-decker-reaffirms-2021-guidance-and-provides" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">as it seeks to acquire the</a>&nbsp;remaining 80% of MTD Products Inc. MTD produces mowers and other outdoor equipment and expects to move toward using more electric motors in the coming years.
Price action:&nbsp;SWK shares closed lower by 0.25% at $194.92 on Friday.

MKTAY

TTNDY

Stanley Black & Decker CFO Explores Battery, Chip Maker Partnerships To Ease Post Pandemic Supply Chain Pressure: WSJ

Earnings

Financing

AQSP

CCHWF

CLVR

CNBS

CRON

FFLWF

FLOOF

HEXO

HYFM

MAPS

MSOS

PCLOF

SHWZ

SSPK

STMH

THCX

YOLO

The Week In Cannabis: Federal Drug Decrim, Connecticut, Louisiana, Big M&A Moves And More

Ammo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poww#NASDAQ">POWW</a>) shares were trading higher Friday as retail traders pushed the stock higher.
The stock looks to be breaking out, and was also trending on social media sites such as StockTwits Friday afternoon. Ammo Inc. trades with a 17-millio-share&nbsp;float, which is slightly lower than average, meaning the stock may be subject to quick movements.
Ammo Inc. gained 7.32% Friday, closing at $7.92.&nbsp;<img alt="powwdaily6-18-21.png" src="https://www.benzinga.com/files/u285825/powwdaily6-18-21.png" style="height:400px; width:640px" />
<h3>Ammo Inc. Daily Chart Analysis</h3>
<ul>
<li>Shares look to have broken out of what technical traders&nbsp;call a pennant pattern. The stock broke above pattern resistance and shares have headed higher.</li>
<li>The stock is trading above both the 50-day moving average (green), and the 200-day moving average (blue), indicating sentiment in the stock is bullish.</li>
<li>Each of these moving averages may hold as an area of support in the future.</li>
</ul>
<h3>Key Ammo Inc. Levels To Watch</h3>
<ul>
<li>Shares looked to have broken out of the pennant pattern after they crossed above the pattern resistance. Shares could see continued momentum if volume in the stock continues rising.</li>
<li>The pennant pattern happens after the stock makes a run up and the price is later condensed between the highs and lows until the price is able to break out of either support or resistance. Typically the stock continues momentum in the same direction as the break.</li>
<li>The Relative Strength Index (RSI) shows that the stock has been becoming more overbought throughout the past couple weeks. This means more buyers are entering into the stock and there are less sellers selling the stock. The stock may reach the overbought range if it is able to reach 70 on the RSI. The stock currently sits at 63 on the RSI.</li>
</ul>
<h3>What&rsquo;s Next For Ammo Inc.?</h3>
Bullish technical traders would like to see the stock continue to rise and stay above 50 on the RSI. Bears would like to see the stock continue to form higher lows and stay above the pattern support. If volume continues to come into the stock at the rate it is, now it could move higher.
Bearish technical traders would like to see the stock fall back into the pennant pattern&nbsp;and then drop below the pattern support. If this were to happen, the stock may change trends and see a downward push. Bears would also like to see the stock fall below 50 on the RSI.

Movers

POWW

Ammo Stock Looks Like It May Be Breaking Out: What's Next?

CanaQuest Names Wall Street Expert Rob Rinderman Director Of Communications

CanaQuest Medical Corp (OTC:<a class="ticker" href="/stock/CANQF#OTC">CANQF</a>) a biotechnology company focusing on cannabis, has hired Rob Rinderman as its new director of communications.

Rinderman has over 35 years of Wall Street investment industry experience.

During his career, he supported a number of companies through the IPO process, follow-on capital raises and acquisitions, as well as crisis communications.

&quot;We believe adding a veteran like Rob to help us present our story to a wider and receptive audience is a key asset for us moving forward,&quot; the company&#39;s President Raul Ramsay <a href="https://ca.finance.yahoo.com/news/canaquest-medical-corp-appoints-investor-123300464.html">said</a> Wednesday.

Tiffany Davis Joins Terra Tech&rsquo;s Board Of Directors

Cannabis agriculture company Terra Tech Corp. (OTCQX:<a class="ticker" href="/stock/TRTC#OTCQX">TRTC</a>) has appointed Tiffany Davis to its board of directors.

Davis brings over two decades of experience in finance within the cannabis sector. She also sharpened her consulting and private equity skills during her career.

Currently, Davis serves as CEO and CFO of Generation Alpha (OTCQB:<a class="ticker" href="/stock/GNAL#OTCQB">GNAL</a>).

&quot;They have a very clear strategy, with a dedicated team focused on promulgating the plan and working on behalf of the shareholders,&quot; Davis <a href="https://www.globenewswire.com/news-release/2021/04/08/2207138/26002/en/Terra-Tech-Corp-Announces-New-Board-Member.html">said</a> Thursday talking about the Irvine, California-based company.

Last month, Terra Tech <a href="https://www.benzinga.com/markets/cannabis/21/03/19973971/terra-tech-buys-unrivaled-expects-70m-in-revenues-and-more-m-a">agreed to purchase</a> Umbrla Inc., which has rebranded as &quot;Unrivaled,&quot; for an undisclosed price.

Steve Nash Endorses BioSteel

Brooklyn Nets coach and two-time MVP Steve Nash opted to partner with BioSteel, a company that&#39;s majority-owned by Canadian cannabis giant Canopy Growth Corporation (TSX:<a class="ticker" href="/stock/WEED#TSX">WEED</a>) (NASDAQ:<a class="ticker" href="/stock/CGC#NASDAQ">CGC</a>).

Nash joins other athletes and brand ambassadors, including NBA star <a href="https://www.benzinga.com/markets/cannabis/21/03/20011884/cannabis-movers-shakers-nusachi-apwc-nabis-amco-wslcb-veritas-vinergy-shield-compliance-biosteel">Luka Dončić</a> and <a href="https://www.benzinga.com/markets/cannabis/20/08/16922717/super-bowl-mvp-patrick-mahomes-joins-biosteel-as-equity-partner">Patrick Mahomes</a>, who opted to endorse the brand of nutritional products.

&ldquo;I only endorse products that I am passionate about,&rdquo; Nash <a href="https://www.canopygrowth.com/investors/news-releases/steve-nash-joins-biosteel-as-newest-ambassador-partner/">said</a> Thursday.

&ldquo;I&rsquo;m excited to be working with BioSteel because I have been hydrating with its zero-sugar sports drink on a daily basis for years,&rdquo; he added.

Halo Co-Founder And COO Andreas Met Steps Down From Board To Help With Lesotho Expansion

Halo Collective Inc. (NEO:HALO) (OTCQB:<a class="ticker" href="/stock/HCANF#OTCQB">HCANF</a>) <a href="https://www.newswire.ca/news-releases/halo-collective-announces-new-appointment-to-board-of-directors-and-completes-securities-issuance-to-independent-consultants-related-parties-and-suppliers-884896631.html">said</a> Friday that Andreas Met, co-founder and chief operating officer, opted to step down from the board of directors.

Met agreed to relocate to Lesotho and help with the expansion of the company&rsquo;s international business operations.

Halo&rsquo;s CFO Philip van den Berg will replace Met on the board. Berg is also a founding partner of Levantis Wealth Control Ltd.

Simultaneously, the Toronto-based company closed the issuance of its 11,877,135 common shares at CA$0.11 per share to the particular independent consultants, related parties, and suppliers.

Rolling Stone Culture Council Welcomes Igor Beuker

Rolling Stone Culture Council has welcomed speaker, entrepreneur and futurist Igor Beuker to its ranks.

Beuker joins the organization following the <a href="https://www.benzinga.com/markets/cannabis/20/12/18892519/cannabis-movers-shakers-medmen-rolling-stone-culture-council-sierra-constellation-cansortium-ter">appointment</a> of Niles Christodoulidis, the CEO of Rebel Roots Farms, Inc., to its cannabis committee.

The invitation-only community, launched last year, gathers professionals, influencers, and innovators across several industries, including cannabis, art, entertainment, fashion, film, food and beverage, gaming, hospitality, media, music, sports, technology, television, and theater.

&ldquo;The members of this community are exceptional, innovative, and true leaders,&rdquo; co-founder of Rolling Stone Culture Council, Scott Gerber, <a href="https://www.prweb.com/releases/igor_beuker_accepted_to_rolling_stone_culture_council_a_community_of_thought_leaders_and_tastemakers_shaping_industry_futures/prweb17849104.htm">said</a> Monday.

&ldquo;We look forward to the insights and thoughtful discussions that will come from them and this new business-based community,&rdquo; Gerber added.

Australis Capital Taps Dr. Jason Dyck As CSO

Australis Capital Inc. (CSE:<a class="ticker" href="/stock/AUSA#CSE">AUSA</a>) (OTCQB:<a class="ticker" href="/stock/AUSAF#OTCQB">AUSAF</a>) <a href="https://www.newswire.ca/news-releases/australis-appoints-dr-jason-dyck-as-chief-science-officer-852558125.html">said</a> Monday it has appointed Dr. Jason Dyck to serve as its new chief science officer and chairman of the scientific advisory board.

Dyck brings vast experience in cannabis-related medical research.

He will oversee the company&#39;s scientific initiatives related to medical and wellness applications for cannabis in his new position.

Prior to this, Dyck supervised the research and science department at Aurora Cannabis (NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>).

&quot;We believe that Jason&#39;s capabilities and connections in medical science and the cannabis industry will prove tremendous assets for the Company as we look to develop commercially valuable innovations for the medical, wellness, and adult-use markets,&quot; Dr. Duke Fu, the company&#39;s COO said Monday.

Fu was <a href="https://www.benzinga.com/markets/cannabis/21/02/19858566/cannabis-movers-shakers-cannformatics-urban-gro-ssdp-agrify-nvg-australis-ppib-fyllo-keirton-crc">appointed</a> to oversee the company&#39;s operations in February.

Photo by <a href="https://unsplash.com/@ryanlange?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Ryan Lange</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

Biotech

Entrepreneurship

Movers & Shakers

Cannabis Movers & Shakers: CanaQuest, Terra Tech, BioSteel, Halo Collective, Rolling Stone Culture Council, Australis

The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More

According to the Canadian Mental Health Commission (CMHC), the economic burden of workplace mental health issues amounts to an astounding $51 billion per year, with 40% attributed to productivity loss. Regarding this link between mental and physical health, chronic pain is much more likely to result in mood disorders.

A 2017 Canadian Tobacco, Alcohol, and Drugs Survey by the CMHC indicated that 37% of cannabis users reported doing so for medical reasons. However, biases persist, with many employers and employees believing that any form of cannabis use impairs a person&rsquo;s ability to function in the workplace.

Fortunately, a wealth of recent cannabis research by companies like CanaQuest Medical Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANQF#OTC">CANQF</a>) has resulted in the development of many wellness-focused products and nutraceuticals utilizing cannabis, hemp and botanical compounds to treat a variety of mental and physical conditions without inebriating effects.

Research has also highlighted the risks and benefits of cannabis within diverse Canadian subpopulations.

<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/O_D4wkHHbDg" width="560"></iframe>

<h3>Embracing Change</h3>

The COVID-19 pandemic has taught many to embrace change and dismantle stigmas as well as to recognize and admit to biases and&nbsp;help&nbsp;create safe work environments.

Now, through a new partnership with the Canadian Cannabis Dispute Resolution Centre (CCDRC), CanaQuest, is seeking to help drive this change by assisting with workplace dispute mediation and provide training on cannabis law and resolution policy.

Commenting on the CanaQuest/CCDRC partnership, Treena Reilkoff, a Trauma Informed Mediator and Facilitator with the CCDRC, explained the concept to&nbsp;Benzinga.&nbsp;&ldquo;Our common goal is the recognition that medicinal cannabis is an alternative treatment to traditional pharmaceuticals and through education about the practicality and safety of medicinal cannabis, barriers and stigmas are reduced.&rdquo;

Photo by <a href="https://unsplash.com/@timmossholder?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Tim Mossholder</a> on <a href="https://unsplash.com/s/photos/mental-health?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

Cannabis For Mental Health In The Workplace: These Organizations Lead The Charge In Canada

ACRGF

AUSAF

CANQF

CSE:AUSA

CSE:CCHW

CSE:GAGE

CSE:GTII

CSE:HBOR

CSE:IMCC

CSE:MMEN

CSE:RWB

CSE:TRIP

GNAL

GTBIF

HBORF

HCANF

IMCC

NXTTF

RWBYF

SNDL

TLRY

TRTC

TRUFF

TSX:FAF

TSX:VLNS

TSX:WEED

TSXV:N

VLNCF

UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE&#174; - OMEGA-3 & PURE CANNABIDIOL ("CBD") FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE

UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-' & PURE ...

Press Releases

CANAQUEST SIGNS MEDICINAL CANNABIS EDUCATION PARTNERSHIP WITH THE CANADIAN CANNABIS DISPUTE RESOLUTION CENTRE

CanaQuest Targeting Same Mental Health Space Where GW Pharma was Acquired for US$7.2BTORONTO, ON / ACCESSWIRE / March 23, 2021 / CANAQUEST MEDICAL CORP (OTC:<a class="ticker" href="/stock/CANQF#OTC">CANQF</a>) (the &quot;Company&quot; or &quot;CanaQuest&quot;), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp (&quot;FRC&quot;), one of the world&#39;s largest independent research houses, has launched coverage on CanaQuest with a BUY Rating. Its full report is available here: <a href="https://pr.report/hUv3wGV5">https://canaquest.com/wp-content/uploads/2021/03/CanaQuest-Research-Report-by-FRC-March-2021.pdf</a>FRC has a 17-year track record of covering 550+ companies since inception. An excerpt from FRC&#39;s report is included below&#8230;&quot;In conclusion, we believe the company&#39;s formulations have potential to generate demand based on their differentiating features. Even though we are not in position to verify the company&#39;s claims regarding higher efficacy levels, we believe recognition by academic journals is highly encouraging. The company&#39;s prospects are heavily dependent on management&#39;s ability to raise capital and obtain approvals. We believe the current financing (if completed), and near-term sales of non-Rx products will be the key catalysts this year. We are initiating coverage with a BUY rating, and a fair value estimate to US$0.78.&quot;About Fundamental Research Corp:Fundamental Research Corp is one of the largest independent research houses in the world, with a 17-year track record of covering 550+ companies. As of March 12, 2021, FRC&#39;s top picks were up 76.4% on average since initiation of coverage. The Company is a premier research firm that has ranked in the Top Ten in independent third-party evaluations of its research.For more information on Fundamental Research Corp, visit <a href="https://pr.report/xCnPQfTk">https://www.researchfrc.com/</a>About CanaQuest Medical Corp:CanaQuest Medical Corp is a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade). The Company is the industry partner for research and product development with Dr. Steven Laviolette, a professor and neuroscientist, who has 20 years of research experience in the field of mental health and cannabinoids and oversees a team of 13 scientists at Western University. The Company&#39;s research is focused on the use of cannabinoids for the development of novel pharmacotherapies for mental health, such as anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder &quot;PTSD&quot;. CanaQuest has identified the regulatory pathways to obtain Drug Identification Numbers (DINs) for its two Master Formations, Mentanine&#174;Rx and Mentabinol&#174;Rx in Canada and the USA.As well, CanaQuest will be selling both products through its wholly owned subsidiary, ADC BioMedical Corp, which was awarded a Cannabis Medical Sales, Import/Export License, from Health Canada under the Cannabis Act. Licenced GMP Contract Manufacturers in Canada and the USA, capable of formulating, processing, and packaging, have been selected for production and distribution. The Company won the Go Global Awards, 2019, &quot;Business of the Year - Category of Life Science,&quot; presented by the International Trade Council.For a short video on the research, visit <a href="https://pr.report/AgpsdoNy">https://www.youtube.com/watch?v=O_D4wkHHbDg</a>For more information on CanaQuest, visit <a href="https://pr.report/Az30pLkn">http://www.canaquest.com</a>FORWARD-LOOKING STATEMENTS This news release contains &quot;forward-looking statements&quot; as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs, and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual Disclosure Statement filed with the OTC Markets for the most recent fiscal year.CANAQUEST CONTACT:Paul Ramsay, Co-Founder &amp; President CanaQuest Medical Corp <a href="mailto:paul@canaquest.com">paul@canaquest.com</a>: Tel.: 416-704-3040SOURCE: CanaQuest Medical Corp. View source version on accesswire.com: <a href='https://www.accesswire.com/636867/Fundamental-Research-Corp-Initiates-Coverage-on-CanaQuest-CANQF-with-Buy-Rating-and-US078-Fair-Value-Estimate'>https://www.accesswire.com/636867/Fundamental-Research-Corp-Initiates-Coverage-on-CanaQuest-CANQF-with-Buy-Rating-and-US078-Fair-Value-Estimate</a> 
 <img src="https://www.accesswire.com/img.ashx?id=636867" width="0" height="0"/>

Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate

TORONTO, ON / ACCESSWIRE / March 29, 2021 / CANAQUEST MEDICAL CORP (OTC:<a class="ticker" href="/stock/CANQF#OTC">CANQF</a>) (the &quot;Company&quot; or &quot;CanaQuest&quot;), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R &amp; D Excellence Award 2020 by Global Health &amp; Pharma, United Kingdom, a global information sharing platform &amp; multi-disciplinary members community.<img alt="" height="400" src="https://www.accesswire.com/users/newswire/images/637829/Fina.jpg" style="width: 300px; height: 400px;" width="300" />About Global Health &amp; Pharma Awards:When it comes to handing out recognition and awards, we believe there are few more deserving than those whose dedication changes the lives of millions of people every day. Our awards recognize innovation and courage in all aspects of the healthcare and pharmaceutical industries, including practitioners, scientists, nurses, architects, product designers, legal specialists and corporate decision makers. We believe all these roles are responsible for the life-changing innovations we see daily. To learn more, please visit <a href="https://pr.report/yFoH9igO">https://www.ghp-news.com/awards/healthcare-pharmaceuticals-awards/</a>.About Global Health &amp; Pharma:GHP is a global information sharing platform &amp; multi-disciplinary members community established to enhance communication &amp; collaboration across Human, Animal and Environmental Health. Global Health &amp; Pharma Magazine is the go-to resource on developing issues in healthcare and pharmaceuticals for over 260,000 wellness professionals and healthcare-related suppliers across four continents. Our informed readership includes individuals at all levels of their respective industries, from CEOs to healthcare professionals, nurses and support service workers.For more information on Global Health &amp; Pharma, visit <a href="https://pr.report/yAfTKYzi">https://www.ghp-news.com/about-us/</a>.About CanaQuest Medical Corp:CanaQuest Medical Corp is a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade). The Company is the industry partner for research and product development with Dr. Steven Laviolette, a professor and neuroscientist, who has 20 years of research experience in the field of mental health, and cannabinoids, and oversees a team of 13 scientists at Western University. The Company&#39;s research is focused on the use of cannabinoids for the development of novel pharmacotherapies for mental health, such as anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder &quot;PTSD&quot;. CanaQuest has identified the regulatory pathways to obtain Drug Identification Numbers (DINs) for its two Master Formations, Mentanine&#174;Rx and Mentabinol&#174;Rx in Canada and the USA.As well, CanaQuest will be selling both products through its wholly-owned subsidiary, ADC BioMedical Corp, which was awarded a Cannabis Medical Sales, Import/Export License, from Health Canada under the Cannabis Act. Licenced GMP Contract Manufacturers in Canada and the USA, capable of formulating, processing, and packaging, have been selected for production and distribution. The Company won the Go Global Awards, 2019, &quot;Business of the Year - Category of Life Science,&quot; presented by the International Trade Council.For a short video on the research, visit <a href="https://pr.report/XIpxgK3Y">https://www.youtube.com/watch?v=O_D4wkHHbDg</a>.For more information on CanaQuest, visit <a href="https://pr.report/mvxF-HRl">http://www.canaquest.com</a>.<img alt="CanaQuest Medical Corp." height="100" src="https://storage.googleapis.com/accesswire/logos/subaccounts/24956.jpg" style="width: 171px; height: 100px;" width="171" />CANAQUEST CONTACT:Paul Ramsay, Co-Founder &amp; President CanaQuest Medical Corp <a href="mailto:paul@canaquest.com">paul@canaquest.com</a> Tel.: 416-704-3040SOURCE: CanaQuest Medical Corp. View source version on accesswire.com: <a href='https://www.accesswire.com/637829/CanaQuest-Medical-Corp-Honored-With-International-CBD-Life-Science-R-D-Excellence-Award-2020-by-Global-Health-Pharma'>https://www.accesswire.com/637829/CanaQuest-Medical-Corp-Honored-With-International-CBD-Life-Science-R-D-Excellence-Award-2020-by-Global-Health-Pharma</a> 
 <img src="https://www.accesswire.com/img.ashx?id=637829" width="0" height="0"/>

CanaQuest Medical Corp Honored With International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma

TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC:<a class="ticker" href="/stock/CANQF#OTC">CANQF</a>) (the &quot;Company&quot; or &quot;CanaQuest&quot;), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing a proactive investor relations and corporate communications program, further expanding investor community and media awareness about the company&#39;s material corporate developments and future prospects.&quot;We are delighted that a seasoned communications professional with decades of financial experience has agreed to join our team at this important time in our corporate evolution,&quot; stated CanaQuest President Paul Ramsay. &quot;We believe adding a veteran like Rob to help us present our story to a wider and receptive audience is a key asset for us moving forward.&quot;Mr. Rinderman brings 35+ years of Wall Street investment industry experience to CanaQuest. After beginning his career in the early 1980s on the American Stock Exchange as a trader and arbitrageur he pivoted his career in the first half of the 1990s to spearheading proactive investor relations programs on behalf of dozens of public companies across multiple sectors and cap sizes, including multibillion-dollar valuations. Mr. Rinderman has guided companies through the IPO process, follow-on capital raises, acquisitions, and crisis communications. He has also worked as a licensed investment banker, passed the CFA Level One, and has an MBA from NYU Stern School.Rob Rinderman added, &quot;I am very excited to join the CanaQuest senior team at this critical corporate inflection point, reflecting a strong foundation built over recent years. Multiple positive developments are converging including demonstrable progress toward a regulatory pathway, completed pre-clinical trials, plus a strong academic research partnership with Dr. Laviolette (Western University), who recently had a peer-reviewed article published in the European Journal of Neuroscience. CanaQuest has strategic alliances in place for product production, distribution and industry education, an imminent direct-to-consumer (D2C) e-commerce launch, IP asset filings, recent BUY-rated investor research coverage, and the Company also recently received international CBD - R&amp;D award recognition.&quot;For more information on Rob Rinderman - <a href="https://pr.report/ksXIEiHQ">https://www.linkedin.com/in/robrinderman/</a>CanaQuest Medical Corp is an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical grade botanical compounds. CanaQuest has identified the regulatory pathways to obtain Drug Identification Numbers (DINs) for its two Master Formations, Mentanine&#174;Rx, and Mentabinol&#174;Rx, in Canada and the USA. The Company will soon be selling both products through ADC BioMedical Corp, its wholly-owned subsidiary, which was awarded a Cannabis Medical Sales, Import/Export License, from Health Canada under the Cannabis Act. CanaQuest is partnered with a Western University team led by Dr. Steven Laviolette, who has decades of research experience focused on novel pharmacotherapies addressing anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder (PTSD).CANAQUEST CONTACT:Rob Rinderman, Director of Communications CanaQuest Medical Corp <a href="mailto:rob@canaquest.com">rob@canaquest.com</a> Tel: 973.525.6285SOURCE: CanaQuest Medical Corp. View source version on accesswire.com: <a href='https://www.accesswire.com/639239/CanaQuest-Medical-Corp-Appoints-Investor-Relations-and-PR-Veteran-Rob-Rinderman-as-its-New-Director-of-Communications'>https://www.accesswire.com/639239/CanaQuest-Medical-Corp-Appoints-Investor-Relations-and-PR-Veteran-Rob-Rinderman-as-its-New-Director-of-Communications</a> 
 <img src="https://www.accesswire.com/img.ashx?id=639239" width="0" height="0"/>

Management

CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

TORONTO, ON / ACCESSWIRE / April 29, 2021 / CANAQUEST MEDICAL CORP (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANQF#OTC">CANQF</a>) (the &quot;Company&quot; or &quot;CanaQuest&quot;), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine&#174;, which has demonstrated at least 10-times (10X) the efficacy compared to Pharma Grade CBD.Mentanine&#174; - an International CBD Excellence Award 2020 formulation was scientifically developed through preclinical trials at Western University. Results of its potential effect on anxiety, depression, PTSD, and schizophrenia have been statistically significant. Our evidence also found that this formulation targeted a specific nuclear cellular receptor involved in anti-inflammatory mechanisms indicating that this formula may also treat inflammatory disorders.&quot;Our CBD-based Mentanine&#174; discovery sets the stage for substantially smaller dosages having the desired results compared to other CBD medications,&quot; stated neuroscientist Dr. Steven Laviolette, who leads a 13-member research team at Western University (Ontario, Canada). &quot;The CBD + specific concentration of Omega-3 fatty assets increases the effects of CBD alone by improving actions on anxiety-related behaviors and improved inhibition of some specific neurochemical pathways linked to anxiety, schizophrenia, and addiction processing. By this mechanism, we believe that lower doses of CBD would be required with this formula to achieve the same efficacy attained from much higher doses of CBD by itself,&quot; he added.Results from the Mentanine&#174; preclinical trials highlight advantages over pure CBD products on the market today, including the FDA-approved CBD drug for treating seizures associated with Lennox-Gastaut and Dravet syndromes.Paul Ramsay, CanaQuest&#39;s Co-Founder and President, said, &quot;The Mentanine formulation further demonstrates the depth and breadth of our scientific research platform and goal of treating anxiety, depression, PTSD, and other debilitating ailments. To date, CBD alone has shown little scientific impact on the ability of the Central Nervous System (CNS) to help with mental health issues. We believe Mentanine&#174; can become a &#8216;life-changer,&#39; improving quality of life for many and without the side effects caused by larger CBD doses,&quot; he emphasized. Regulatory Pathway and Drug Identification Number (DIN) There is strong evidence from preclinical trial results that CanaQuest&#39;s modified formulation, in combination with its proprietary processing and delivery method, is also a very promising epilepsy treatment. The Company is collaborating with experienced parties to initiate the application process, including human trials to obtain approval for an Rx Drug Identification Number (DIN) for rare diseases under the umbrella of Epilepsy from the US FDA and Health Canada. The Company believes the DIN approval process time requirement will be significantly reduced, reflecting the proven regulatory pathway and previous approvals for other products containing CBD and THC.<ul><li>Physicians interested in joining our network, as well as clinics and pharmacies, should register at <a href="https://pr.report/YgIR0Qmk">www.canaquest.com</a>.</li></ul><ul><li>Customers and patients can register at <a href="mailto:info@canaqueststore.com">info@canaqueststore.com</a> for updates on product developments.</li></ul><ul><li>CanaQuest is entering discussions with domestic and international medical cannabis distributors. Please contact us with indications of interest.</li></ul>CanaQuest Medical Corp is an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds. The Company has developed two commercial-ready Master Formulations, Mentanine&#174; and Mentabinol&#174;, for treating mental health ailments. CanaQuest has also identified the regulatory pathways to obtain Rx Drug Identification Numbers (DINs) in Canada and the USA for Epilepsy rare diseases. The modified Mentanine&#174; formulation, in combination with its proprietary processing and delivery method, is very promising for epilepsy treatment as an Rx drug. The Company will be selling both products in the coming months to patients through ADC BioMedical Corp, its wholly-owned subsidiary, which was awarded a Cannabis Medical Sales Import/Export License from Health Canada under the Cannabis Act. CanaQuest is a leader in scientifically-backed cannabinoid products in collaboration with multiple Canadian universities including a Western University team led by Dr. Steven Laviolette, who has decades of research experience focused on novel pharmacotherapies addressing anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder (PTSD).FORWARD-LOOKING STATEMENTS This news release contains &quot;forward-looking statements&quot; as defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the use of proceeds and the development, costs, and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual Disclosure Statement filed with the OTC Markets for the most recent fiscal year.<img height="150" src="https://www.accesswire.com/users/newswire/images/642737/image-20210428144729-1.jpeg" style="width: 257px; height: 150px;" width="257" />CANAQUEST CONTACT: Rob Rinderman, Director of Communications CanaQuest Medical Corp <a href="mailto:rob@canaquest.com">rob@canaquest.com</a> Tel: 973.525.6285SOURCE: CanaQuest Medical Corp View source version on accesswire.com: <a href='https://www.accesswire.com/642737/CanaQuest-Files-International-MentanineR-Patent-a-Scientific-CBD-Formulation-for-Mental-Health'>https://www.accesswire.com/642737/CanaQuest-Files-International-MentanineR-Patent-a-Scientific-CBD-Formulation-for-Mental-Health</a> 
 <img src="https://www.accesswire.com/img.ashx?id=642737" width="0" height="0"/>

CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

Recent Quotes

Related Companies

CanaQuest Medical Frequently Asked Questions

How do I buy CanaQuest Medical (CANQF) stock?

Who are CanaQuest Medical's (CANQF) competitors?

What is the target price for CanaQuest Medical (CANQF) stock?

Current Stock Price for CanaQuest Medical (CANQF)?

Does CanaQuest Medical (CANQF) pay a dividend?

When is CanaQuest Medical (OTC:CANQF) reporting earnings?

Is CanaQuest Medical (CANQF) going to split?

What sector and industry does CanaQuest Medical (CANQF) operate in?